Related Experiment Video
Updated: Sep 18, 2025

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines
Published on: March 17, 2023
Metabolic Reprogramming in Melanoma: An Epigenetic Point of View
Stefano Giuliani1, Celeste Accetta2, Simona di Martino2
1SAFU, Department of Research, Advanced Diagnostics and Technological Innovation, IRCCS-Regina Elena National Cancer Institute, 00144 Rome, Italy.
Abstract:
Metabolic reprogramming and epigenetic alterations are fundamental hallmarks of cancer cells, contributing to adaptation, progression, and resistance. In melanoma, high metabolic-epigenetic plasticity enables the rapid modulation of cell states in response to environmental and therapeutic pressures. Recent studies have highlighted a bidirectional crosstalk between cellular metabolism and epigenetic regulation. Epigenetic modifications influence the transcriptional control of metabolic genes, thereby shaping metabolic phenotypes. Conversely, specific metabolites are essential cofactors or substrates for epigenetic enzymes, directly modulating the epigenome. Understanding the intricate mechanisms of this interaction offers opportunities for the development of innovative tumor management that combines epigenetic, metabolic, and therapy interventions. In this review, we summarize the latest evidence on the role of the metabolism-epigenetics axis in melanoma and discuss its potential clinical implications, aiming to provide a comprehensive overview of metabolic/epigenetic interconnections.
Related Concept Videos
Somatic to iPS Cell Reprogramming
Epigenetic Regulation
X-chromosome...
Methods of Nuclear Reprogramming
Introduction to Nuclear Reprogramming
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Regulation of Metabolism

